Jan 07, 2009
Monsanto Takes Major Step Toward Launch of World's First Drought-Tolerant Corn Product
Higher-Yielding Soybeans, SmartStax Corn, and Dicamba- and Glufosinate- Tolerant Cotton Also Move Forward in Company's Research & Development Pipeline
Jan 07, 2009
Monsanto Increases Full-Year Ongoing Earnings-Per-Share Guidance After Reporting 117% Earnings Growth in First Quarter of Fiscal 2009
The company announced that it is raising full-year earnings-per-share (EPS) guidance from a range of $4.20 to $4.40 to a range of $4.40 to $4.50 on an ongoing basis. As discussed further in Note 1, at this time the company is not able to provide a reconciliation to reported EPS guidance for fiscal year 2009. The company reported net sales of $2.6 billion for the first quarter of fiscal 2009, a 29 percent increase compared to the first quarter of fiscal 2008.
Monsanto recorded net income of $556 million for the first quarter of fiscal 2009, a 117 percent increase compared with net income of $256 million for the same period last year. Earnings per share (EPS) for the quarter were $1.00 on an as-reported basis and $0.98 on an ongoing basis, compared to year-ago EPS of $0.46 on an as-reported basis and $0.45 on an ongoing basis. The quarter's results included $44 million, or $0.08 per share, in discrete tax items.
Jan 06, 2009
Monsanto Announces Yield Gains With Deltapine Class Of 09
Combination of Elite Genetics and Second Generation Traits Outyield Market Standards
Dec 16, 2008
Plant Health Care And Monsanto Sign Final Agreement For The Commercialization Of Harpin Technology
Plant Health Care Inc, a wholly owned subsidiary of Plant Health Care plc (AIM: PHC), and Monsanto Company (NYSE: MON) have entered into an agreement for the commercialization of harpin-based technology as a seed treatment in Monsanto’s major row crops and vegetables. The harpin technology offers farmers in-season benefits, including the suppression of pests like nematodes and yield-inhibiting diseases, as well as additive plant health benefits. The technology is a specific type of protein that activates a plant's intrinsic ability to protect itself and enhances growth. Over the past year Monsanto has evaluated the technology and will proceed to continue commercial development of harpin seed treatment as part of its global seed treatment platform.
Dec 10, 2008
Monsanto Vice President and Treasurer Robert A. Paley to Retire; Tom D. Hartley to Succeed Paley
Dec 09, 2008
Monsanto Leverages Extensive R&D Platform to Deliver Yield Benefits to Farmers
Chief Technology Officer to Announce Roundup Ready 2 Yield 2008 Soybean Yield Data, Highlights 2009 Launch and Yield Advantage for Farmers
Dec 08, 2008
Monsanto Company Declares Quarterly Dividend
Monsanto Company today announced that its Board of Directors has declared a quarterly dividend on its common stock of 24 cents per share. The dividend relates to the company's first quarter of its 2009 fiscal year. The dividend is payable on January 30, 2009, to shareowners of record on January 9, 2009.
Dec 04, 2008
Monsanto's Roundup Ready 2 Yield™ Soybeans Receive European Union Regulatory Import Approval
Dec 02, 2008
Monsanto Company Completes Acquisitions of CanaVialis and Alellyx
Monsanto Company (NYSE: MON) announced that it has completed its proposed acquisition of Aly Participacoes Ltda., which operates the sugarcane breeding and technology companies, CanaVialis S.A. and Alellyx S.A., both of which are based in Brazil. Monsanto's $290 million (R$616 million) acquisition of Aly Participacoes Ltda. from Votorantim Novos Negocios Ltda. and its sister company, Votorantim Industrial S.A., was consummated with existing excess cash.
Nov 18, 2008
Monsanto Announces 2008 Preliminary Corn Yield Data; Head-to-Head Trials Underscore Economic Value U.S. Farmers Receive From Monsanto Corn Products
Yield data highlights that farmers see strong boost from DEKALB and American Seeds Inc. genetics, receive $25 to $65 in additional value per acre using DEKALB products
Nov 07, 2008
Monsanto Completes Expansion of Jerseyville Facility, Home of World's First Biotechnolgy Field Trial
Three Million Dollar Expansion Includes a New Office Building and New Seed Processing Facility
Oct 08, 2008
Monsanto Sees Record Sales in Fiscal Year 2008; Growth Serves as Strong Base for 2009
Monsanto increases gross profit target for 2012 to $9.5 billion to $9.75 billion
Monsanto reported record net sales of $2 billion for the fourth quarter of fiscal year 2008, which were 35 percent higher than sales in the same period in fiscal year 2007. Monsanto saw record net sales of $11.4 billion in the company's fiscal year 2008, which were 36 percent higher than sales in fiscal year 2007. Monsanto reported a net loss of $172 million in the fourth quarter of fiscal year 2008, compared with a reported net loss of $210 million in the same period last year.
Monsanto said that its full-year 2009 EPS guidance, on an as-reported and ongoing basis, is in the range of $4.20 to $4.40. The company's 2009 EPS guidance reflects a projected growth rate of approximately 15 percent to 20 percent from the fiscal year 2008 EPS ongoing base of $3.64 per share. Monsanto announced that it now expects that gross profit for the entire company will grow to $9.5 billion to $9.75 billion for 2012, or roughly two- and-a-quarter times the company's 2007 base. This estimate exceeds the company's prior gross profit estimate of $8.6 billion to $9.1 billion. The company also noted that it expects to realize a compound annual growth rate for gross profit of 18 percent to 20 percent through 2012.
Oct 02, 2008
Monsanto Increases 2008 Earnings-Per-Share Guidance, With Growth Continuing From the Company's Seeds-and-Traits and Roundup Businesses
Monsanto indicated that it now expected ongoing EPS guidance for 2008 in the range of $3.64 and revised its reported EPS guidance in the range of $3.59. In mid-September, the company indicated it expected ongoing EPS guidance in the range of $3.58 to $3.60, with reported EPS in the range of $3.49 to $3.51.
As a part of the announcement on the year-end expectations today, Monsanto also increased the targets for the 2009 fiscal year and its 2012 long-term targets for the Roundup business. Previously, Monsanto indicated it expected the full year gross profit contribution from Roundup for 2009 to be in the range of $2.1 billion to $2.2 billion. Given additional clarity going into fiscal year 2009, Monsanto now expects that Roundup will generate in the range of $2.3 billion to $2.4 billion in gross profit in fiscal year 2009. The company also increased the 2012 gross-profit target to $1.9 billion from its original target of $1.8 billion.
Oct 02, 2008
Monsanto Company Completes Sale of POSILAC Bovine Somatotropin and Related Business
Monsanto Company (NYSE: MON) announced that it has completed the sale of its POSILAC® bovine somatotropin brand and related business to Eli Lilly and Company (NYSE: LLY). Under the terms of the agreement, Lilly purchased assets and liabilities of Monsanto associated with the POSILAC brand and related business for an upfront payment of $300 million, plus additional contingent consideration. POSILAC bovine somatotropin is an FDA-approved animal pharmaceutical used by U.S. dairy farmers to increase productivity.
Sep 16, 2008
Monsanto Revises Full-Year 2008 Earnings Per Share Guidance Based on Better Than Anticipated Results for Seeds and Traits
Monsanto Company (NYSE: MON) raised its fiscal year 2008 ongoing earnings per share (EPS) guidance to a range of $3.58 to $3.60, and revised its reported EPS guidance to a range of $3.49 to $3.51, compared with its previously announced EPS guidance of $3.37 on an ongoing basis, and $3.63 on an as reported basis, Monsanto's Chief Financial Officer Terry Crews, will tell investors today. The change in ongoing earnings reflected higher-than-expected sales and gross profit in the company's seeds and traits business and its Roundup® and other glyphosate- based herbicide business.
Aug 20, 2008
Eli Lilly and Company to Acquire Monsanto's POSILAC Brand Dairy Product and Related Business
Aug 06, 2008
Monsanto Company Declares Quarterly Dividend
Monsanto Company (NYSE: MON) today announced that its Board of Directors has declared a quarterly dividend on its common stock of 24 cents per share. The dividend relates to the company's fourth quarter of its 2008 fiscal year. The dividend is payable on October 24, 2008, to shareowners of record on October 3, 2008.
Jul 24, 2008
New Insect Protection Technology From Monsanto Company Deregulated by USDA
Second Generation Corn Borer Technology Offers Greater Control of Common Pests and Provides Reduced Refuge Opportunity for Southern U.S. Growers
Jul 02, 2008
Monsanto Company Completes Acquisition of Semillas Cristiani Burkard
Monsanto Company (NYSE: MON) announced that it has completed its proposed acquisition of Marmot, S.A., which operates Semillas Cristiani Burkard (SCB), a privately-held seed company headquartered in Guatemala City, Guatemala. SCB is the leading Central American corn seed company focused on hybrid corn production. The company has long-standing relationships with farmers and works with more than 900 dealers in the Central American region. The acquisition will build on Monsanto's corn business leadership in Latin and Central America, and enable it to offer farmers in Central American countries broader access to corn seed products.
Jun 23, 2008
BASF and Monsanto Enter Into Agreement for New Fungicide Seed Treatment Solution In Soybeans
Jun 19, 2008
Monsanto Company Announces Agreement to Acquire Semillas Cristiani Burkard, the Leading Central American Corn Seed Company
Acquisition expected to expand Monsanto's hybrid corn portfolio in Central America enabling it to deliver dependable, high-yielding seeds to farmers.
Jun 13, 2008
Monsanto Company Completes Acquisition of De Ruiter Seeds
Monsanto Company (NYSE: MON) announced today that it has completed its proposed acquisition of De Ruiter Seeds Group B.V., a Dutch-holding company that owns and operates De Ruiter Seeds, for Euro 546 million in cash, or approximately $850 million at current exchange rates, less net debt.
Apr 28, 2008
Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
Apr 16, 2008
Monsanto Adds Janice L. Fields to Board of Directors
Apr 16, 2008
Monsanto Company Announces new Three-Year Share Repurchase Program
New Program Reflects Focus on Using Strong Cash Position to Benefit Shareowners
Monsanto's Board of Directors authorized a new share repurchase program for up to $800 million of the company's common stock over a three-year period. This repurchase program will commence at the time the company's current share repurchase program is completed or its original target of October 2009, whichever is earlier.
Mar 31, 2008
Monsanto Company Announces Agreement to Acquire De Ruiter Seeds, a Leading Global Vegetable Seed Company
Acquisition expected to expand Monsanto's vegetable seed portfolio in the fast-growing protected-culture segment, enable it to accelerate the delivery of value-added products to growers and consumers
Mar 25, 2008
Monsanto Boosts Fiscal-Year 2008 Earnings Per Share and Free Cash Flow Guidance
Second-Quarter Results Exceed Expectations Given Upside from Seeds-and-Traits and Roundup Businesses
The company now projects full-year ongoing EPS of $3.15 to $3.25, an increase versus the previous ongoing guidance of $2.70 to $2.80. For the second-quarter, the company expects ongoing EPS in the range of $1.75. As-reported EPS is expected to be in the range of $1.98 for the second quarter and in the range of $3.38 to $3.48 for the full year. Both periods will be affected favorably by $0.23 per share from the settlement of Monsanto's claims in conjunction with Solutia's emergence from bankruptcy.
Given the increased level of operating cash, Monsanto (NYSE: MON) now expects free cash flow of approximately $1.4 billion for the fiscal year versus prior guidance of $900 million to $1 billion. The company expects net cash provided by operating activities to be in the range of $2.45 billion, and net cash required by investing activities to be approximately $1.05 billion for fiscal year 2008.
Feb 12, 2008
Monsanto Increases Full-Year 2008 Ongoing Earnings per Share Guidance Based on Strong Demand for Seeds and Traits, Roundup and Other Glyphosate-Based Herbicides
Growing adoption of corn and soybean products by U.S. and Latin American farmers propel business, adoption sets up growth footprint for near-term trait offerings
Monsanto (NYSE: MON) has raised its fiscal year 2008 ongoing earnings per share (EPS) guidance to a range of $2.70 to $2.80, compared with its previously announced range of $2.50 to $2.60, reflecting increased confidence in its seed and traits business commitments and continuing strong performance of its Roundup and other glyphosate-based herbicides business, Monsanto's Executive Vice President of Global Commercial business, Brett Begemann, will tell investors today. Monsanto now expects its glyphosate business could deliver between $1.3 billion to $1.4 billion of gross profit in fiscal year 2008. Begemann will also confirm that Monsanto's seed and traits business is expected to contribute approximately $3.5 billion of gross profit in fiscal year 2008.
Jan 16, 2008
Monsanto Company Declares Quarterly Dividend
Monsanto Company (NYSE: MON) today announced that its Board of Directors has declared a quarterly dividend on its common stock of 17.5 cents per share. The dividend relates to the company's second quarter of its 2008 fiscal year and will be payable on April 25, 2008, to shareowners of record on April 4, 2008.
Jan 03, 2008
Higher Sales of Monsanto's Roundup, Seeds and Traits Businesses in Latin America Drive First-Quarter Results
Monsanto Raises Full-Year EPS and Free Cash Flow Guidance
The company reported net sales of $2.1 billion for the first quarter of fiscal year 2008, which were 36 percent higher than those in the first quarter of fiscal year 2007. The results in the quarter reflect the strong performance of the company's businesses outside the United States. Key drivers for the quarter were increased sales of Roundup agricultural herbicides in Brazil, Argentina and Europe, as well as stronger adoption of the company's seed and trait technologies in Brazil and Argentina.
For the first quarter of fiscal year 2008, Monsanto recorded net income of $256 million compared with net income of $90 million for the same period last year. Earnings per share (EPS) for the quarter, both on an as-reported and ongoing basis, were 46 cents a share. The second and third quarters of fiscal year 2008 are expected to be the primary drivers for the company's fiscal year 2008 EPS results. These quarters reflect both the relative size of the company's U.S. business and the importance of its seeds-and-traits business to Monsanto's earnings.
